Apotex and two partners advanced a complex sterile injectable program designed for use in parenteral nutrition. Gland Pharma contributed commercial manufacturing readiness through its sterile ...
WESTON, Fla., April 14, 2026 /CNW/ - Apotex Corp., in partnership with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma Limited, today announced that the U.S. Food and Drug ...
WESTON, Fla., April 27, 2026 /CNW/ - Apotex, in collaboration with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma Limited, today announced that the U.S. Food and Drug Administration ...
The company is eligible for 180‑day CGT exclusivity for single‑dose vial. Together, the two approvals represent a coordinated advancement in expanding access to parenteral nutrition options for both ...
Apotex, in collaboration with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma Limited, announced that the US Food and Drug Administration (FDA) has approved the Abbreviated New Drug ...
The MarketWatch News Department was not involved in the creation of this content. WESTON, Fla., April 14, 2026 /PRNewswire/ - Apotex Corp., in partnership with Orbicular Pharmaceutical Technologies ...